Weiss Asset Management LP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 175 filers reported holding ANI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
Weiss Asset Management LP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$3,868,000
-31.1%
47,054
-40.9%
0.24%
-46.5%
Q1 2019$5,613,000
+15.7%
79,571
-26.2%
0.44%
+28.7%
Q4 2018$4,852,000
+163.6%
107,771
+230.9%
0.34%
+141.8%
Q3 2018$1,841,000
+145.5%
32,565
+179.8%
0.14%
+116.9%
Q4 2017$750,000
-90.8%
11,639
-92.5%
0.06%
-92.8%
Q3 2017$8,141,000
+299.1%
155,089
+255.7%
0.90%
+330.0%
Q2 2017$2,040,00043,5960.21%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
Sio Capital Management, LLC 40,000$1,124,0000.37%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders